Healthcare -
Biotechnology - NASDAQ - US
$ 2.6
4 %
$ 358 M
Market Cap
-7.43
P/E
CMPX - STOCK-BASED COMPENSATION
Stock-based Compensation CMPX - Compass Therapeutics, Inc.
6.12 M
LAST VALUE
23.25%
2 YEAR CAGR
56.30%
5 YEAR CAGR
0.00%
10 YEAR CAGR